Denali Therapeutics stockDNLI
Denali Therapeutics trades at $19.72, 27.8% below its 52-week high (Jul 9, 2026). The price is below its 50- and 200-day averages, a downtrend. +19.4% year to date, +32.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 1, 2027.
Ratings, candles, signals and the screener for DNLI — after you log in
Open the terminalFrequently asked questions about Denali Therapeutics
What is the Denali Therapeutics stock price?
At the close on Nov 5, 2026: $19.72 (−5.92% on the day). 52-week high: $27.30 on Jul 9, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Denali Therapeutics report earnings?
The next quarterly report is on Mar 1, 2027. Last quarter, earnings per share changed +150% year over year, revenue 0%.
Does Denali Therapeutics pay dividends?
No, Denali Therapeutics does not pay dividends.
Where does Denali Therapeutics trade and how to buy it?
Ticker DNLI, exchange Nasdaq, listed since 2017. You can buy it through a broker with access to US exchanges.
Should I buy Denali Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for DNLI are in the terminal after you log in.